Healthcare -
Biotechnology - NASDAQ - US
$ 43.55
-2.09 %
$ 1.67 B
Market Cap
-14.19
P/E
TARS - OPERATING EXPENSES
Operating Expenses TARS - Tarsus Pharmaceuticals, Inc.
159 M
LAST VALUE
53.93%
2 YEAR CAGR
159.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR